Loading...

Gene Therapy Adoption And Payer Coverage Will Drive Powerful Long Term Upside

Published
19 Dec 25
Views
2
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
-10.4%
7D
-4.7%

Author's Valuation

US$2881.8% undervalued intrinsic discount

AnalystHighTarget Fair Value